Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Feinstein to offer limited BPA amendment

This article was originally published in The Tan Sheet

Executive Summary

Sen. Dianne Feinstein will offer an amendment to food safety legislation banning bisphenol A in products intended for children, she announced Aug. 14. It would ban the use of the compound in packaging for infant formula and baby food within six months of the bill's enactment and require FDA to issue a safety assessment by Dec. 31. "The Food Safety Bill was the logical place for this legislation, and I have been working hard to reach a compromise, but unfortunately BPA language is not included," she said. It was previously reported that the California Democrat would offer a broader amendment banning the chemical from all food containers, a move that could imperil industry support for the food safety overhaul. The legislation, which has bipartisan support, is expected to come to the Senate floor soon after the chamber returns from August recess (1"The Tan Sheet" Aug. 16, 2010)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel